Although high plasma galectin-3 levels seem to correlate with the severity of SAH, subsequent development of delayed cerebral infarction without cerebral vasospasm, and poor outcomes [76,77], the functional role and molecular mechanisms of galectin-3 in SAH remain unclear. This evidence concerns the gene LGALS3 and cerebral infarction.